Both Traders and Investors Should Get to Know ABC

Positive earnings and break above long-term resistance make AmerisourceBergen a buy

   
Both Traders and Investors Should Get to Know ABC

AmerisourceBergen Corp. (NYSE:ABC) — This pharmaceutical services company provides drug distribution primarily in the United States and Canada. 

On Thursday, the company reported Q4 FY 2012 earnings of $0.72 per share, beating analyst estimates of $0.68. Despite a slight revenue shortfall, on Friday, S&P raised its price target to $46. 

ABC also increased its dividend by 62% to $0.84 a share and announced a new $750 million multi-year share repurchase plan. 

Technically, ABC has confirmed a break above long-term resistance at $40. Buy at the current price or on a pullback. The trading target for ABC is $46, but long-term investors could achieve much higher returns.

10 05 12 abc 300x218 Both Traders and Investors Should Get to Know ABC
Click to Enlarge

chart key 300x84 Both Traders and Investors Should Get to Know ABC


Article printed from InvestorPlace Media, http://investorplace.com/2012/11/trade-of-the-day-amerisourcebergen-corp-nyse-abc/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.